Redwood City, CA, United States of America

Rachelle Copeland

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Codexis, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachelle Copeland. Retrieved from https://idiyas.com/inventor/rachelle-copeland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rachelle Copeland and Engineered DNA Ligase Innovation.

Introduction

Rachelle Copeland is an inventor associated with Redwood City, California, and Codexis, Inc. Her patent work concerns engineered DNA ligase technology, which has potential applications in diagnostics and molecular biology.

Latest Patents

Copeland is named on one patent, titled “Engineered DNA Ligase Variants.” The disclosure describes engineered DNA ligase polypeptides, compositions containing them, and polynucleotides that encode them. It also outlines using these ligases and compositions in diagnostic applications and as tools in molecular biology.

Career Highlights

The patent reflects work on modifying DNA ligases and developing related biological tools. Such technologies can support research and diagnostic methods that rely on DNA manipulation.

Collaborations

Copeland’s listed coworkers include Jovana Nazor and Jonathan Vroom. The patent is associated with Codexis, Inc.

Conclusion

Rachelle Copeland’s patent contribution centers on engineered DNA ligase variants and their potential uses in diagnostics and molecular biology, representing a focused innovation in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…